Stock data
Mangoceuticals, Inc. (MGRX)
Mangoceuticals, Inc. (MGRX) reported revenue of US$0.46M and net income of -US$20.64M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.46M | US$0.25M | -US$18.03M | -US$20.64M | — |
| 2024 | US$0.62M | US$0.38M | -US$7.97M | -US$8.71M | — |
| 2023 | US$0.73M | US$0.43M | -US$9.22M | -US$9.21M | — |
| 2022 | US$0.01M | US$0.00M | -US$1.99M | -US$2.00M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.07M | -US$1.31M | — |
| 2026-03-31 | US$0.07M | -US$3.40M | — |
| 2025-12-31 | US$0.09M | -US$2.77M | — |
| 2025-09-30 | US$0.08M | -US$7.62M | — |
| 2025-06-30 | US$0.17M | -US$5.42M | — |
| 2025-03-31 | US$0.11M | -US$4.84M | — |
| 2024-12-31 | US$0.11M | -US$1.95M | — |
| 2024-09-30 | US$0.13M | -US$2.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.